CSI Market
Sign In | Register

Northwest Biotherapeutics Inc (NWBO) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access NWBO Annual Balance Sheets →
The data below summarizes Northwest Biotherapeutics Inc's balance sheet position from Jun 30 2025 to Jun 30 2026, enabling a period-by-period comparison of financial strength.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent0.60
Cash & Short-term Investments0.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current1.98
Total Current Assets2.57
Equipment/Property/Plant Net25.18
Goodwill net0.63
Intangible Assets51.93
Other Assets, Noncurrent0.00
Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss Current-
Total Assets75.94
Liabilities
Accounts Payable and Accrued Liabilities, Current LI32.53
Derivative Liability, Current DE0.00
Notes Payable, Current NO10.25
Other Liabilities, Current0.00
Deferred Compensation Share-based Arrangements, Liability, Current DE10.21
Business Combination, Contingent Consideration, Liability, Current BU0.00
Total Current Liabilities73.35
Long-term debt51.97
Convertible Notes Payable, Noncurrent LO1.23
Total Long-term Debt53.20
Other liabilities, Noncurrent14.54
Share Liability0.37
Operating Lease Liability Current0.27
Convertible Notes At Fair Value Current30.83
Convertible Notes At Fair Value Non Current7.51
Contingent Payment Obligation Noncurrent1.70
Total Liabilities110.72
Stockholders' Equity
Common Stock Value1.68
Common Stock, Held by Subsidiary etc.0.08
Additional Paid In Capital Common Stock1,469.43
Retained Earnings / Accumulated Deficit-1,515.95
Accumulated Other Comprehensive Income-0.25
Other Equity-0.25
Common Stockholder's Equity-45.17
Non-controlling interests & other0.00
Total Stockholder's Equity-45.17
Liabilities & Stockholder's Equity75.94
4 historic quarters locked

Sign in to unlock the full Northwest Biotherapeutics Inc balance sheet history.

Sign In Create Free Account

About Northwest Biotherapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001104659-26-097188

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.